Repurposing the drug, ivermectin, in COVID-19: toxicological points of view

The global COVID-19 pandemic has affected the world’s population by causing changes in behavior, such as social distancing, masking, restricting people’s movement, and evaluating existing medication as potential therapies. Many pre-existing medications such as tocilizumab, ivermectin, colchicine, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirazi, Farshad M., Mirzaei, Roya, Nakhaee, Samaneh, Nejatian, Amir, Ghafari, Shokouh, Mehrpour, Omid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817475/
https://www.ncbi.nlm.nih.gov/pubmed/35123559
http://dx.doi.org/10.1186/s40001-022-00645-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817475/
https://www.ncbi.nlm.nih.gov/pubmed/35123559
http://dx.doi.org/10.1186/s40001-022-00645-8

Ejemplares similares